TYRA BIOSCIENCES INCTYRA
ASignal's systematic analysis rates TYRA as Neutral.
Reflects the latest available analysis · analyzed Sep 13, 2026
The case on TYRA
Bull vs bear, surfaced by ASignal's framework agents from public market data. The precise verdict: ASignal Rank, confidence, and price targets - is in the app.
- Strong financial health score (0.9)
- Low debt-to-equity ratio (0.02x)
- High cash position ($353.94M)
- Strong liquidity (current ratio 14.90x)
- Positive news coverage from trusted sources including Barrons.com and SeekingAlpha
- Bearish MACD trend (MACD < signal line)
- Negative price momentum (-0.117)
- Negative return on equity (-45.31%)
- Negative operating cash flow ($-109.65M)
- No Reddit retail sentiment data available
- Negative forward P/E (-7.64x) and EV/EBITDA (-6.04x) suggesting valuation challenges
See the full verdict on TYRA
ASignal Rank (1-4), confidence score, Buffett / Ackman / Dalio grades, price targets, and the full reasoning behind the call.
How ASignal analyzes TYRA
Most investors never get a second opinion, let alone several. ASignal runs TYRA past a panel of specialized investor-framework agents, each calibrated on a distinct school of investing: Warren Buffett's value discipline, Bill Ackman's activist lens, and Ray Dalio's macro view. They don't just score in isolation, they argue: a dedicated Challenger agent pushes back on every conclusion until the panel settles on a reasoned consensus, weighing fundamentals, macro conditions, market sentiment, and price action together. The kind of cross-examined read that takes a research desk hours, ASignal delivers in under two minutes, refreshed every cycle.
The signal direction and the bull and bear case above are free. The precise read, ASignal Rank, framework grades, price targets, and full reasoning, stays with subscribers.